Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
Quality Management in Health Care|December 26, 2013
Physician nonadherence with a hepatitis C screening programWilliam N Southern, Mari-Lynn Drainoni, Bryce D Smith, et al.Viruses|August 29, 2024
Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis <i>C Virus</i> Who Inject DrugsAkhila Padi, Irene Pericot-Valverde, Moonseong Heo, et al.Contemporary Clinical Trials|April 10, 2021
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderNikhil Seval, Cynthia A Frank, Alain H Litwin, et al.American Journal of Public Health|September 22, 2012
Effectiveness of a risk screener in identifying hepatitis C virus in a primary care settingMari-Lynn Drainoni, Alain H Litwin, Bryce D Smith, et al.Journal of Medical Internet Research|September 20, 2024
Uncovering the Complexity of Perinatal Polysubstance Use Disclosure Patterns on X: Mixed Methods StudyDezhi Wu, Hannah Shead, Yang Ren, et al.Journal of Substance Abuse Treatment|June 21, 2022
Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugsAlison Karasz, Reena Singh, M Diane McKee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2019
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsSarah Gutkind, Bruce R Schackman, Jake R Morgan, et al.Kidney Medicine|August 1, 2020
Group-Based Care in Adults and Adolescents With Hypertension and CKD: A Feasibility StudyTanya S Johns, Denver D Brown, Alain H Litwin, et al.Journal of Substance Use|November 6, 2024
Influence of polysubstance use on the health-related quality of life among people who inject drugs undergoing opioid agonist treatment following treatment for hepatitis c virusMirinda Ann Gormley, Wanfang Zhang, Stella Self, et al.Journal of Addiction Medicine|August 14, 2023
Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical TrialNikhil Seval, Johnathan Nunez, Prerana Roth, et al.Pageof 16